Key result
Treatment with colchicine and aspirin successfully resolved acute pericarditis secondary to SARS-CoV-2 infection in a 71-year-old kidney transplant recipient.
Why the study?
There is currently no standard of therapy for SARS-CoV-2-related pericarditis, and cardiac manifestations represent an increasingly identified non-respiratory complication.
Case Report (n=1)
No
Acute pericarditis is a rare complication of SARS-CoV-2 that can be successfully managed with colchicine and aspirin, even in immunocompromised kidney transplant recipients.
May support colchicine-aspirin in transplant recipients with COVID pericarditis; hypothesis-generating, needs prospective validation.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is highly contagious and typically presents with respiratory complications. Non-respiratory etiology has been increasingly identified in the literature, including cardiac manifestations. Here, we discuss an atypical case recently treated for SARS-CoV-2 presenting with acute pericarditis. Our patient's medical history of autoimmune disease and renal transplant further complicated her care. There is currently no standard of therapy for SARS-CoV-2-related pericarditis. We would like to highlight increased awareness of this rare complication as well as successful treatment regimens for acute management of the disease.
No takes yet. Share an insight, caveat, or question.
Gill et al. (2021) conducted a case report in Acute Pericarditis due to SARS-COV-2 (n=1). Colchicine and aspirin was evaluated on Symptom improvement. Treatment with colchicine and aspirin successfully resolved acute pericarditis secondary to SARS-CoV-2 infection in a 71-year-old kidney transplant recipient.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: